Regarding the “Efgartigimod versus standard of care in new-onset AChR subtype generalized myasthenia gravis: A prospective cohort study”

Haifeng Li(Capital Medical University), Yansu Guo(Capital Medical University), Shi‐Min Hu(Center for Information Technology), Wei Han(Chinese University of Hong Kong)
Clinical Immunology
September 12, 2025
10.1016/j.clim.2025.110603
Cited by 0

Related Papers

Attention mechanisms in computer vision: A survey
|Computational Visual Media|2022|2.3k
Visual attention network
|Computational Visual Media|2023|955
Global CNS Transduction of Adult Mice by Intravenously Delivered rAAVrh.8 and rAAVrh.10 and Nonhuman Primates by rAAVrh.10
|Molecular Therapy|2014|211
Aggressive intraoperative warming versus routine thermal management during non-cardiac surgery (PROTECT): a multicentre, parallel group, superiority trial
|The Lancet|2022|117
Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model
|Neuroscience|2015|96